169 495

Cited 43 times in

Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association

DC Field Value Language
dc.contributor.author이용호-
dc.contributor.author이병완-
dc.contributor.author차봉수-
dc.date.accessioned2020-09-29T00:44:40Z-
dc.date.available2020-09-29T00:44:40Z-
dc.date.issued2020-06-
dc.identifier.issn2233-6079-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/179385-
dc.description.abstractThis clinical practice position statement, a product of the Fatty Liver Research Group of the Korean Diabetes Association, proposes recommendations for the diagnosis, progression and/or severity assessment, management, and follow-up of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM). Patients with both T2DM and NAFLD have an increased risk of non-alcoholic steatohepatitis (NASH) and fibrosis and a higher risk of cardiovascular diseases and diabetic complications compared to those without NAFLD. With regards to the evaluation of patients with T2DM and NAFLD, ultrasonography-based stepwise approaches using noninvasive biomarker models such as fibrosis-4 or the NAFLD fibrosis score as well as imaging studies such as vibration-controlled transient elastography with controlled attenuation parameter or magnetic resonance imaging-proton density fat fraction are recommended. After the diagnosis of NAFLD, the stage of fibrosis needs to be assessed appropriately. For management, weight reduction achieved by lifestyle modification has proven beneficial and is recommended in combination with antidiabetic agent(s). Evidence that some antidiabetic agents improve NAFLD/NASH with fibrosis in patients with T2DM is emerging. However, there are currently no definite pharmacologic treatments for NAFLD in patients with T2DM. For specific cases, bariatric surgery may be an option if indicated.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherKorean Diabetes Association-
dc.relation.isPartOfDIABETES & METABOLISM JOURNAL-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleNon-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorByung Wan Lee-
dc.contributor.googleauthorYong Ho Lee-
dc.contributor.googleauthorCheol Young Park-
dc.contributor.googleauthorEun Jung Rhee-
dc.contributor.googleauthorWon Young Lee-
dc.contributor.googleauthorNan Hee Kim-
dc.contributor.googleauthorKyung Mook Choi-
dc.contributor.googleauthorKeun Gyu Park-
dc.contributor.googleauthorYeon Kyung Choi-
dc.contributor.googleauthorBong Soo Cha-
dc.contributor.googleauthorDae Ho Lee-
dc.contributor.googleauthorKorean Diabetes Association (KDA) Fatty Liver Research Group-
dc.identifier.doi10.4093/dmj.2020.0010-
dc.contributor.localIdA02989-
dc.contributor.localIdA02796-
dc.contributor.localIdA03996-
dc.relation.journalcodeJ00720-
dc.identifier.eissn2233-6087-
dc.identifier.pmid32431115-
dc.subject.keywordCardiovascular disease-
dc.subject.keywordDiabetes mellitus, type 2-
dc.subject.keywordLife style-
dc.subject.keywordNon-alcoholic fatty liver disease-
dc.contributor.alternativeNameLee, Yong Ho-
dc.contributor.affiliatedAuthor이용호-
dc.contributor.affiliatedAuthor이병완-
dc.contributor.affiliatedAuthor차봉수-
dc.citation.volume44-
dc.citation.number3-
dc.citation.startPage382-
dc.citation.endPage401-
dc.identifier.bibliographicCitationDIABETES & METABOLISM JOURNAL, Vol.44(3) : 382-401, 2020-06-
dc.identifier.rimsid67276-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.